Cerus Corporation (CERS)
USD 1.35
(3.85%)
USD 1.35
(3.85%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 95.99 Million USD | 10.04% |
| 2022 | 87.23 Million USD | -0.4% |
| 2021 | 87.58 Million USD | 30.94% |
| 2020 | 66.89 Million USD | 3.79% |
| 2019 | 64.45 Million USD | 115.77% |
| 2018 | 29.87 Million USD | 0.24% |
| 2017 | 29.79 Million USD | 53.8% |
| 2016 | 19.37 Million USD | -2.5% |
| 2015 | 19.87 Million USD | 101.3% |
| 2014 | 9.87 Million USD | 193.29% |
| 2013 | 3.36 Million USD | -56.42% |
| 2012 | 7.72 Million USD | 7.04% |
| 2011 | 7.21 Million USD | 47.45% |
| 2010 | 4.89 Million USD | 20291.67% |
| 2009 | 24 Thousand USD | 0.0% |
| 2008 | - USD | -100.0% |
| 2007 | 32 Thousand USD | -72.41% |
| 2006 | 116 Thousand USD | -97.66% |
| 2005 | 4.96 Million USD | -87.28% |
| 2004 | 39 Million USD | -30.17% |
| 2003 | 55.85 Million USD | 109415.69% |
| 2002 | 51 Thousand USD | -37.8% |
| 2001 | 82 Thousand USD | -29.31% |
| 2000 | 116 Thousand USD | 16.0% |
| 1999 | 100 Thousand USD | -98.0% |
| 1998 | 5 Million USD | 4900.0% |
| 1997 | 100 Thousand USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 98.69 Million USD | -1.9% |
| 2024 Q3 | 97.89 Million USD | -0.8% |
| 2024 Q1 | 100.6 Million USD | 4.8% |
| 2023 Q4 | 95.99 Million USD | 1.14% |
| 2023 FY | 95.99 Million USD | 10.04% |
| 2023 Q1 | 89.94 Million USD | 3.1% |
| 2023 Q3 | 94.91 Million USD | 7.85% |
| 2023 Q2 | 88.01 Million USD | -2.15% |
| 2022 Q4 | 87.23 Million USD | -0.24% |
| 2022 FY | 87.23 Million USD | -0.4% |
| 2022 Q2 | 87.96 Million USD | -0.65% |
| 2022 Q1 | 88.53 Million USD | 1.08% |
| 2022 Q3 | 87.45 Million USD | -0.58% |
| 2021 Q2 | 81.84 Million USD | -1.08% |
| 2021 Q3 | 82.35 Million USD | 0.62% |
| 2021 Q4 | 87.58 Million USD | 6.35% |
| 2021 FY | 87.58 Million USD | 30.94% |
| 2021 Q1 | 82.73 Million USD | 23.69% |
| 2020 Q4 | 66.89 Million USD | 5.1% |
| 2020 Q2 | 63.85 Million USD | -0.27% |
| 2020 Q1 | 64.02 Million USD | -0.66% |
| 2020 FY | 66.89 Million USD | 3.79% |
| 2020 Q3 | 63.64 Million USD | -0.32% |
| 2019 Q4 | 64.45 Million USD | 0.06% |
| 2019 FY | 64.45 Million USD | 115.77% |
| 2019 Q1 | 60.3 Million USD | 101.89% |
| 2019 Q3 | 64.41 Million USD | 0.25% |
| 2019 Q2 | 64.25 Million USD | 6.55% |
| 2018 Q3 | 29.85 Million USD | 0.06% |
| 2018 Q2 | 29.83 Million USD | 0.06% |
| 2018 Q1 | 29.81 Million USD | 0.06% |
| 2018 FY | 29.87 Million USD | 0.24% |
| 2018 Q4 | 29.87 Million USD | 0.06% |
| 2017 Q1 | 18.15 Million USD | -6.29% |
| 2017 FY | 29.79 Million USD | 53.8% |
| 2017 Q4 | 29.79 Million USD | 0.06% |
| 2017 Q3 | 29.78 Million USD | 70.54% |
| 2017 Q2 | 17.46 Million USD | -3.83% |
| 2016 Q2 | 19.85 Million USD | 0.13% |
| 2016 FY | 19.37 Million USD | -2.5% |
| 2016 Q3 | 19.35 Million USD | -2.53% |
| 2016 Q4 | 19.37 Million USD | 0.12% |
| 2016 Q1 | 19.82 Million USD | -0.22% |
| 2015 Q1 | 9.88 Million USD | 0.11% |
| 2015 Q4 | 19.87 Million USD | 0.08% |
| 2015 Q3 | 19.85 Million USD | -0.19% |
| 2015 Q2 | 19.89 Million USD | 101.3% |
| 2015 FY | 19.87 Million USD | 101.3% |
| 2014 Q1 | 3.26 Million USD | -2.91% |
| 2014 Q4 | 9.87 Million USD | 0.12% |
| 2014 FY | 9.87 Million USD | 193.29% |
| 2014 Q2 | 9.84 Million USD | 201.35% |
| 2014 Q3 | 9.86 Million USD | 0.12% |
| 2013 Q3 | 3.63 Million USD | 68.66% |
| 2013 Q4 | 3.36 Million USD | -7.48% |
| 2013 FY | 3.36 Million USD | -56.42% |
| 2013 Q1 | 6.95 Million USD | -9.96% |
| 2013 Q2 | 2.15 Million USD | -68.99% |
| 2012 FY | 7.72 Million USD | 7.04% |
| 2012 Q4 | 7.72 Million USD | -6.1% |
| 2012 Q3 | 8.22 Million USD | 11.03% |
| 2012 Q2 | 7.4 Million USD | 2.55% |
| 2012 Q1 | 7.22 Million USD | 0.12% |
| 2011 Q3 | 4.91 Million USD | 21.69% |
| 2011 Q4 | 7.21 Million USD | 46.97% |
| 2011 Q2 | 4.03 Million USD | -9.89% |
| 2011 Q1 | 4.47 Million USD | -8.5% |
| 2011 FY | 7.21 Million USD | 47.45% |
| 2010 FY | 4.89 Million USD | 20291.67% |
| 2010 Q3 | 4.87 Million USD | 0.41% |
| 2010 Q4 | 4.89 Million USD | 0.43% |
| 2010 Q2 | 4.85 Million USD | 8.69% |
| 2010 Q1 | 4.46 Million USD | 18504.17% |
| 2009 FY | 24 Thousand USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2009 Q3 | 26 Thousand USD | 0.0% |
| 2009 Q4 | 24 Thousand USD | -7.69% |
| 2009 Q2 | - USD | 0.0% |
| 2008 Q3 | 9000.00 USD | -47.06% |
| 2008 FY | - USD | -100.0% |
| 2008 Q2 | 17 Thousand USD | -29.17% |
| 2008 Q4 | - USD | -100.0% |
| 2008 Q1 | 24 Thousand USD | -25.0% |
| 2007 FY | 32 Thousand USD | -72.41% |
| 2007 Q3 | 38 Thousand USD | -41.54% |
| 2007 Q4 | 32 Thousand USD | -15.79% |
| 2007 Q2 | 65 Thousand USD | -34.34% |
| 2007 Q1 | 99 Thousand USD | -14.66% |
| 2006 Q1 | 219 Thousand USD | -95.59% |
| 2006 Q2 | 167 Thousand USD | -23.74% |
| 2006 Q3 | 141 Thousand USD | -15.57% |
| 2006 Q4 | 116 Thousand USD | -17.73% |
| 2006 FY | 116 Thousand USD | -97.66% |
| 2005 Q4 | 4.96 Million USD | 4.75% |
| 2005 Q3 | 4.73 Million USD | 1.94% |
| 2005 FY | 4.96 Million USD | -87.28% |
| 2005 Q1 | 4.55 Million USD | -88.32% |
| 2005 Q2 | 4.64 Million USD | 1.95% |
| 2004 Q3 | 60.1 Million USD | 2.41% |
| 2004 Q4 | 39 Million USD | -35.12% |
| 2004 Q2 | 58.69 Million USD | 838428.57% |
| 2004 Q1 | 7000.00 USD | -99.99% |
| 2004 FY | 39 Million USD | -30.17% |
| 2003 FY | 55.85 Million USD | 109415.69% |
| 2003 Q3 | 54.44 Million USD | 2.82% |
| 2003 Q4 | 55.85 Million USD | 2.59% |
| 2003 Q2 | 52.95 Million USD | 2.9% |
| 2003 Q1 | 51.45 Million USD | 100800.0% |
| 2002 Q3 | 59 Thousand USD | -11.94% |
| 2002 Q4 | 51 Thousand USD | -13.56% |
| 2002 Q1 | 76 Thousand USD | -7.32% |
| 2002 FY | 51 Thousand USD | -37.8% |
| 2002 Q2 | 67 Thousand USD | -11.84% |
| 2001 Q2 | 96 Thousand USD | -6.8% |
| 2001 Q4 | 82 Thousand USD | -7.87% |
| 2001 FY | 82 Thousand USD | -29.31% |
| 2001 Q3 | 89 Thousand USD | -7.29% |
| 2001 Q1 | 103 Thousand USD | -11.21% |
| 2000 Q4 | 116 Thousand USD | -3.33% |
| 2000 FY | 116 Thousand USD | 16.0% |
| 2000 Q1 | 138 Thousand USD | 38.0% |
| 2000 Q2 | 129 Thousand USD | -6.52% |
| 2000 Q3 | 120 Thousand USD | -6.98% |
| 1999 Q2 | 5 Million USD | 0.0% |
| 1999 Q1 | 5 Million USD | 0.0% |
| 1999 Q3 | 100 Thousand USD | -98.0% |
| 1999 Q4 | 100 Thousand USD | 0.0% |
| 1999 FY | 100 Thousand USD | -98.0% |
| 1998 Q4 | 5 Million USD | -1.96% |
| 1998 FY | 5 Million USD | 4900.0% |
| 1998 Q1 | 100 Thousand USD | 0.0% |
| 1998 Q3 | 5.1 Million USD | -39.29% |
| 1998 Q2 | 8.4 Million USD | 8300.0% |
| 1997 Q4 | 100 Thousand USD | -50.0% |
| 1997 Q1 | 200 Thousand USD | 0.0% |
| 1997 FY | 100 Thousand USD | 0.0% |
| 1997 Q2 | 200 Thousand USD | 0.0% |
| 1997 Q3 | 200 Thousand USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| AdaptHealth Corp. | 2.29 Billion USD | 95.816% |
| Anika Therapeutics, Inc. | 29.03 Million USD | -230.609% |
| Accelerate Diagnostics, Inc. | 39.22 Million USD | -144.771% |
| BrainsWay Ltd. | 471 Thousand USD | -20281.953% |
| CVRx, Inc. | 30.61 Million USD | -213.589% |
| electroCore, Inc. | 626 Thousand USD | -15235.304% |
| Heart Test Laboratories, Inc. | 1.03 Million USD | -9163.291% |
| NeuroOne Medical Technologies Corporation | 184.4 Thousand USD | -51960.195% |
| Helius Medical Technologies, Inc. | 57 Thousand USD | -168319.298% |
| Orthofix Medical Inc. | 134.19 Million USD | 28.465% |
| Treace Medical Concepts, Inc. | 70.3 Million USD | -36.55% |
| iCAD, Inc. | 461 Thousand USD | -20724.078% |
| IceCure Medical Ltd | 599 Thousand USD | -15926.544% |
| 908 Devices Inc. | 5.94 Million USD | -1514.786% |
| Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | -3988.543% |
| Movano Inc. | 252 Thousand USD | -37994.841% |
| MaxCyte, Inc. | 18.74 Million USD | -412.186% |
| Nexalin Technology, Inc. | 4463.00 USD | -2150897.087% |
| PAVmed Inc | 48.72 Million USD | -97.022% |
| Insulet Corporation | 1.44 Billion USD | 93.374% |
| Quanterix Corporation | 41.46 Million USD | -131.524% |
| RxSight, Inc. | 3.01 Million USD | -3087.218% |
| Sight Sciences, Inc. | 35.41 Million USD | -171.076% |
| Sintx Technologies, Inc. | 4.24 Million USD | -2161.461% |
| Surmodics, Inc. | 29.4 Million USD | -226.472% |
| TriSalus Life Sciences, Inc. | 1.59 Million USD | -5918.746% |
| Vivos Therapeutics, Inc. | 1.99 Million USD | -4711.98% |
| Venus Concept Inc. | 79.69 Million USD | -20.455% |
| NeuroPace, Inc. | 72.39 Million USD | -32.604% |
| LENSAR, Inc. | 2.3 Million USD | -4057.601% |
| Rapid Micro Biosystems, Inc. | 7.34 Million USD | -1206.82% |
| SI-BONE, Inc. | 38.99 Million USD | -146.202% |
| TELA Bio, Inc. | 42.78 Million USD | -124.402% |
| Tivic Health Systems, Inc. | 369 Thousand USD | -25915.989% |
| Lucid Diagnostics Inc. | 15.25 Million USD | -529.295% |
| LivaNova PLC | 640.4 Million USD | 85.01% |
| Bioventus Inc. | 409.47 Million USD | 76.556% |
| Envoy Medical, Inc. | 404 Thousand USD | -23662.129% |
| Cytek Biosciences, Inc. | 33.17 Million USD | -189.38% |
| Spectral AI, Inc. | 1.28 Million USD | -7347.556% |
| Nano-X Imaging Ltd. | 8.39 Million USD | -1043.39% |
| Aethlon Medical, Inc. | 940.31 Thousand USD | -10109.228% |
| Inogen, Inc. | 21.92 Million USD | -337.892% |
| OrthoPediatrics Corp. | 23.76 Million USD | -304.036% |
| Alphatec Holdings, Inc. | 541.67 Million USD | 82.278% |
| DIH Holding US, Inc. Warrants | 1.99 Million USD | -4708.365% |
| Apyx Medical Corporation | 38.5 Million USD | -149.342% |
| Cutera, Inc. | 431.91 Million USD | 77.773% |
| STRATA Skin Sciences, Inc. | 15.63 Million USD | -514.079% |
| BioSig Technologies, Inc. | 452 Thousand USD | -21138.717% |
| ClearPoint Neuro, Inc. | 13.94 Million USD | -588.609% |
| Integra LifeSciences Holdings Corporation | 1.68 Billion USD | 94.291% |
| Axonics, Inc. | 27.61 Million USD | -247.608% |
| Outset Medical, Inc. | 136.18 Million USD | 29.51% |
| Monogram Orthopaedics, Inc. | 491.99 Thousand USD | -19412.349% |
| IRIDEX Corporation | 2.74 Million USD | -3395.958% |
| PROCEPT BioRobotics Corporation | 79.2 Million USD | -21.205% |
| IRadimed Corporation | 2.04 Million USD | -4598.824% |
| INVO Bioscience, Inc. | 8.68 Million USD | -1005.526% |
| Viemed Healthcare, Inc. | 10.27 Million USD | -834.644% |
| Varex Imaging Corporation | 469.5 Million USD | 79.553% |
| Quipt Home Medical Corp. | 98.94 Million USD | 2.976% |
| BIOLASE, Inc. | 17.91 Million USD | -436.008% |
| Beyond Air, Inc. | 17.83 Million USD | -438.201% |
| Pulmonx Corporation | 41.42 Million USD | -131.747% |
| Modular Medical, Inc. | 1.19 Million USD | -7967.143% |
| ReShape Lifesciences Inc. | 262 Thousand USD | -36540.84% |
| FONAR Corporation | 41.67 Million USD | -130.347% |
| Semler Scientific, Inc. | 70 Thousand USD | -137041.429% |
| InMode Ltd. | 9.01 Million USD | -964.645% |
| Bruker Corporation | 1.37 Billion USD | 93.042% |
| Cytosorbents Corporation | 18.31 Million USD | -424.208% |
| DexCom, Inc. | 2.59 Billion USD | 96.299% |
| Align Technology, Inc. | 96.96 Million USD | 0.999% |
| ZimVie Inc. | 521.92 Million USD | 81.607% |
| Nexalin Technology, Inc. | 4463.00 USD | -2150897.087% |
| DIH Holdings US, Inc. Class A Common Stock | 1.99 Million USD | -4708.365% |
| Tandem Diabetes Care, Inc. | 415.66 Million USD | 76.905% |
| Profound Medical Corp. | 7.9 Million USD | -1115.12% |
| Vivani Medical, Inc. | 20.69 Million USD | -363.853% |
| enVVeno Medical Corporation | 1.4 Million USD | -6747.29% |
| Inari Medical, Inc. | 32.04 Million USD | -199.557% |
| UFP Technologies, Inc. | 46.03 Million USD | -108.526% |
| QT Imaging Holdings, Inc. | 3.07 Million USD | -3025.922% |
| Nuwellis, Inc. | 981 Thousand USD | -9685.831% |
| iRhythm Technologies, Inc. | 129.82 Million USD | 26.055% |
| InspireMD, Inc. | 1.59 Million USD | -5918.746% |
| PAVmed Inc. | 48.72 Million USD | -97.022% |
| AxoGen, Inc. | 69.29 Million USD | -38.543% |
| Tactile Systems Technology, Inc. | 50.37 Million USD | -90.569% |
| Co-Diagnostics, Inc. | 2.99 Million USD | -3110.06% |
| Tenon Medical, Inc. | 1.17 Million USD | -8084.058% |
| Autonomix Medical, Inc. Common Stock | 1 Million USD | -9480.739% |
| NanoVibronix, Inc. | 5000.00 USD | -1919880.0% |
| Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | -3988.543% |
| Sensus Healthcare, Inc. | 783 Thousand USD | -12160.409% |
| Pacific Biosciences of California, Inc. | 933.93 Million USD | 89.721% |
| TransMedics Group, Inc. | 515.94 Million USD | 81.394% |
| ReWalk Robotics Ltd. | 1.9 Million USD | -4944.614% |
| NeuroMetrix, Inc. | 240.87 Thousand USD | -39754.116% |
| Hyperfine, Inc. | 185 Thousand USD | -51791.351% |
| Establishment Labs Holdings Inc. | 192.22 Million USD | 50.059% |
| Biomerica, Inc. | 785 Thousand USD | -12129.172% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 449.48 Thousand USD | -21257.649% |
| Bluejay Diagnostics, Inc. | 370.1 Thousand USD | -25838.315% |
| Silk Road Medical, Inc | 84.63 Million USD | -13.43% |